Alzheimer's disease and the autophagic-lysosomal system

Neuroscience Letters

Volumn 697, Issue , 2019, Pages 49-58

  Chung, Kyung Min ^a   Hernández, Nancy ^a   Sproul, Andrew A ^a   Yu, Wai Haung ^a  

^a Department of Medicine   (United States)

Author keywords

Alzheimer's disease; Amyloid; Autophagic lysosomal system; Protein clearance; Proteinopathy; Tau

Indexed keywords

AMYLOID BETA PROTEIN; LIPID; TAU PROTEIN;

ALZHEIMER DISEASE; AUTOPHAGY; BIOENERGY; GLIA; HUMAN; LYSOSOME; MITOCHONDRIAL BIOGENESIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 85047197943     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2018.05.017     Document Type: Review

References (164)

1. Blennow, K., de Leon, M.J., Zetterberg, H., Alzheimer's disease. Lancet 368 (2006), 387–403.
2. Nixon, R.A., Wegiel, J., Kumar, A., Yu, W.H., Peterhoff, C., Cataldo, A., Cuervo, A.M., Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64 (2005), 113–122.
3. Boland, B., Kumar, A., Lee, S., Platt, F.M., Wegiel, J., Yu, W.H., Nixon, R.A., Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 28 (2008), 6926–6937.
4. Dubois, B., Feldman, H.H., Jacova, C., Cummings, J.L., Dekosky, S.T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N.C., Galasko, D., Gauthier, S., Hampel, H., Jicha, G.A., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Sarazin, M., de Souza, L.C., Stern, Y., Visser, P.J., Scheltens, P., Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9 (2010), 1118–1127.
5. Cheng, X.T., Zhou, B., Lin, M.Y., Cai, Q., Sheng, Z.H., Axonal autophagosomes recruit dynein for retrograde transport through fusion with late endosomes. J. Cell Biol. 209 (2015), 377–386.
6. Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, C.J., Brown, S.D., Rubinsztein, D.C., Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 37 (2005), 771–776.
7. Lee, S., Sato, Y., Nixon, R.A., Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 31 (2011), 7817–7830.
8. Jansen, A.H., Reits, E.A., Hol, E.M., The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front. Mol. Neurosci., 7, 2014, 73.
9. Vilchez, D., Boyer, L., Morantte, I., Lutz, M., Merkwirth, C., Joyce, D., Spencer, B., Page, L., Masliah, E., Berggren, W.T., Gage, F.H., Dillin, A., Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature 489 (2012), 304–308.
10. Giaume, C., Kirchhoff, F., Matute, C., Reichenbach, A., Verkhratsky, A., Glia: the fulcrum of brain diseases. Cell Death Differ. 14 (2007), 1324–1335.
11. Rodriguez, J.J., Olabarria, M., Chvatal, A., Verkhratsky, A., Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 16 (2009), 378–385.
12. Pomilio, C., Pavia, P., Gorojod, R.M., Vinuesa, A., Alaimo, A., Galvan, V., Kotler, M.L., Beauquis, J., Saravia, F., Glial alterations from early to late stages in a model of Alzheimer's disease: evidence of autophagy involvement in Abeta internalization. Hippocampus 26 (2016), 194–210.
13. Cho, M.H., Cho, K., Kang, H.J., Jeon, E.Y., Kim, H.S., Kwon, H.J., Kim, H.M., Kim, D.H., Yoon, S.Y., Autophagy in microglia degrades extracellular beta-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy 10 (2014), 1761–1775.
14. Yu, W.H., Cuervo, A.M., Kumar, A., Peterhoff, C.M., Schmidt, S.D., Lee, J.H., Mohan, P.S., Mercken, M., Farmery, M.R., Tjernberg, L.O., Jiang, Y., Duff, K., Uchiyama, Y., Naslund, J., Mathews, P.M., Cataldo, A.M., Nixon, R.A., Macroautophagy–a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171 (2005), 87–98.
15. Yang, D.S., Stavrides, P., Mohan, P.S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S.D., Wesson, D.W., Bandyopadhyay, U., Jiang, Y., Pawlik, M., Peterhoff, C.M., Yang, A.J., Wilson, D.A., St George-Hyslop, P., Westaway, D., Mathews, P.M., Levy, E., Cuervo, A.M., Nixon, R.A., Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy 7 (2011), 788–789.
16. Rohn, T.T., Wirawan, E., Brown, R.J., Harris, J.R., Masliah, E., Vandenabeele, P., Depletion of Beclin 1 due to proteolytic cleavage by caspases in the Alzheimer's disease brain. Neurobiol. Dis. 43 (2011), 68–78.
17. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., Schneider, M.D., Levine, B., Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005), 927–939.
18. Supnet, C., Bezprozvanny, I., Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. Cell Calcium 50 (2011), 303–309.
19. Lee, J.H., McBrayer, M.K., Wolfe, D.M., Haslett, L.J., Kumar, A., Sato, Y., Lie, P.P., Mohan, P., Coffey, E.E., Kompella, U., Mitchell, C.H., Lloyd-Evans, E., Nixon, R.A., Presenilin 1 maintains lysosomal Ca(2 + ) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep. 12 (2015), 1430–1444.
20. Cataldo, A.M., Peterhoff, C.M., Schmidt, S.D., Terio, N.B., Duff, K., Beard, M., Mathews, P.M., Nixon, R.A., Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology. J. Neuropathol. Exp. Neurol. 63 (2004), 821–830.
21. Bordi, M., Berg, M.J., Mohan, P.S., Peterhoff, C.M., Alldred, M.J., Che, S., Ginsberg, S.D., Nixon, R.A., Autophagy flux in CA1 neurons of Alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy 12 (2016), 2467–2483.
22. Majumder, S., Richardson, A., Strong, R., Oddo, S., Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One, 6, 2011, e25416.
23. Spilman, P., Podlutskaya, N., Hart, M.J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., Galvan, V., Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One, 5, 2010, e9979.
24. Feng, Y., Yao, Z., Klionsky, D.J., How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol. 25 (2015), 354–363.
25. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., Goldberg, A.L., Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78 (1994), 761–771.
26. Lilienbaum, A., Relationship between the proteasomal system and autophagy. Int. J. Biochem. Mol. Biol. 4 (2013), 1–26.
27. Myeku, N., Clelland, C.L., Emrani, S., Kukushkin, N.V., Yu, W.H., Goldberg, A.L., Duff, K.E., Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat. Med. 22 (2016), 46–53.
28. Cuervo, A.M., Dice, J.F., Lysosomes, a meeting point of proteins, chaperones, and proteases. J. Mol. Med. (Berl.) 76 (1998), 6–12.
29. Hamilton, R.L., Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 10 (2000), 378–384.
30. Wirths, O., Bayer, T.A., Intraneuronal Abeta accumulation and neurodegeneration: lessons from transgenic models. Life Sci. 91 (2012), 1148–1152.
31. LaFerla, F.M., Green, K.N., Oddo, S., Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8 (2007), 499–509.
32. Caccamo, A., Majumder, S., Richardson, A., Strong, R., Oddo, S., Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285 (2010), 13107–13120.
33. Jaeger, P.A., Pickford, F., Sun, C.H., Lucin, K.M., Masliah, E., Wyss-Coray, T., Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS One, 5, 2010, e11102.
34. Zheng, L., Terman, A., Hallbeck, M., Dehvari, N., Cowburn, R.F., Benedikz, E., Kagedal, K., Cedazo-Minguez, A., Marcusson, J., Macroautophagy-generated increase of lysosomal amyloid beta-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy 7 (2011), 1528–1545.
35. Pickford, F., Masliah, E., Britschgi, M., Lucin, K., Narasimhan, R., Jaeger, P.A., Small, S., Spencer, B., Rockenstein, E., Levine, B., Wyss-Coray, T., The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118 (2008), 2190–2199.
36. Nilsson, P., Loganathan, K., Sekiguchi, M., Matsuba, Y., Hui, K., Tsubuki, S., Tanaka, M., Iwata, N., Saito, T., Saido, T.C., Abeta secretion and plaque formation depend on autophagy. Cell Rep. 5 (2013), 61–69.
37. Funderburk, S.F., Wang, Q.J., Yue, Z., The Beclin 1-VPS34 complex–at the crossroads of autophagy and beyond. Trends Cell Biol. 20 (2010), 355–362.
38. Nixon, R.A., Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease. FASEB J. 31 (2017), 2729–2743.
39. Scholz, T., Mandelkow, E., Transport and diffusion of Tau protein in neurons. Cell. Mol. Life Sci. 71 (2014), 3139–3150.
40. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., Hof, P.R., Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33 (2000), 95–130.
41. Cardenas-Aguayo Mdel, C., Gomez-Virgilio, L., DeRosa, S., Meraz-Rios, M.A., The role of tau oligomers in the onset of Alzheimer's disease neuropathology. ACS Chem Neurosci 5 (2014), 1178–1191.
42. Nizynski, B., Dzwolak, W., Nieznanski, K., Amyloidogenesis of tau protein. Protein Sci., 2017, 10.1002/pro.3275.
43. Wolfe, M.S., Tau mutations in neurodegenerative diseases. J. Biol. Chem. 284 (2009), 6021–6025.
44. Pritchard, S.M., Dolan, P.J., Vitkus, A., Johnson, G.V., The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics. J. Cell. Mol. Med. 15 (2011), 1621–1635.
45. Arendt, T., Stieler, J.T., Holzer, M., Tau and tauopathies. Brain Res. Bull. 126 (2016), 238–292.
46. Lee, M.J., Lee, J.H., Rubinsztein, D.C., Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog. Neurobiol. 105 (2013), 49–59.
47. Cuervo, A.M., Dice, J.F., A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273 (1996), 501–503.
48. Wang, Y., Martinez-Vicente, M., Kruger, U., Kaushik, S., Wong, E., Mandelkow, E.M., Cuervo, A.M., Mandelkow, E., Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 18 (2009), 4153–4170.
49. Waters, S., Marchbank, K., Solomon, E., Whitehouse, C., Gautel, M., Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover. FEBS Lett. 583 (2009), 1846–1852.
50. Johansen, T., Lamark, T., Selective autophagy mediated by autophagic adapter proteins. Autophagy 7 (2011), 279–296.
51. Lamark, T., Kirkin, V., Dikic, I., Johansen, T., NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. ABBV Cell Cycle 8 (2009), 1986–1990.
52. D'Agostino, C., Nogalska, A., Cacciottolo, M., Engel, W.K., Askanas, V., Abnormalities of NBR1 a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol. 122 (2011), 627–636.
53. Caccamo, A., Magri, A., Medina, D.X., Wisely, E.V., Lopez-Aranda, M.F., Silva, A.J., Oddo, S., mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell 12 (2013), 370–380.
54. Ramesh Babu, J., Lamar Seibenhener, M., Peng, J., Strom, A.L., Kemppainen, R., Cox, N., Zhu, H., Wooten, M.C., Diaz-Meco, M.T., Moscat, J., Wooten, M.W., Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J. Neurochem. 106 (2008), 107–120.
55. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., Goedert, M., Alpha-synuclein in Lewy bodies. Nature 388 (1997), 839–840.
56. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D.A., Kondo, J., Ihara, Y., Saitoh, T., Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 11282–11286.
57. Lippa, C.F., Fujiwara, H., Mann, D.M., Giasson, B., Baba, M., Schmidt, M.L., Nee, L.E., B. O'Connell, D.A., Pollen, P., St George-Hyslop, B., Ghetti, D., Nochlin, T.D., Bird, N.J., Cairns, V.M., Lee, T., Iwatsubo, J.Q., Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153 (1998), 1365–1370.
58. Bennett, M.C., Bishop, J.F., Leng, Y., Chock, P.B., Chase, T.N., Mouradian, M.M., Degradation of alpha-synuclein by proteasome. J. Biol. Chem. 274 (1999), 33855–33858.
59. Rideout, H.J., Larsen, K.E., Sulzer, D., Stefanis, L., Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 78 (2001), 899–908.
60. Ancolio, K., Alves da Costa, C., Ueda, K., Checler, F., Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells. Neurosci. Lett. 285 (2000), 79–82.
61. Tofaris, G.K., Layfield, R., Spillantini, M.G., alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509 (2001), 22–26.
62. Webb, J.L., Ravikumar, B., Atkins, J., Skepper, J.N., Rubinsztein, D.C., Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278 (2003), 25009–25013.
63. Lee, H.J., Khoshaghideh, F., Patel, S., Lee, S.J., Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 24 (2004), 1888–1896.
64. Cuervo, A.M., Stefanis, L., Fredenburg, R., Lansbury, P.T., Sulzer, D., Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305 (2004), 1292–1295.
65. Larson, M.E., Sherman, M.A., Greimel, S., Kuskowski, M., Schneider, J.A., Bennett, D.A., Lesne, S.E., Soluble alpha-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J. Neurosci. 32 (2012), 10253–10266.
66. Magen, I., Fleming, S.M., Zhu, C., Garcia, E.C., Cardiff, K.M., Dinh, D., De La Rosa, K., Sanchez, M., Torres, E.R., Masliah, E., Jentsch, J.D., Chesselet, M.F., Cognitive deficits in a mouse model of pre-manifest Parkinson's disease. Eur. J. Neurosci. 35 (2012), 870–882.
67. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., McCluskey, L.F., Miller, B.L., Masliah, E., Mackenzie, I.R., Feldman, H., Feiden, W., Kretzschmar, H.A., Trojanowski, J.Q., Lee, V.M., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006), 130–133.
68. Amador-Ortiz, C., Lin, W.L., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff-Radford, N.R., Hutton, M.L., Dickson, D.W., TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61 (2007), 435–445.
69. Josephs, K.A., Murray, M.E., Whitwell, J.L., Parisi, J.E., Petrucelli, L., Jack, C.R., Petersen, R.C., Dickson, D.W., Staging TDP-43 pathology in Alzheimer's disease. Acta Neuropathol. 127 (2014), 441–450.
70. Herman, A.M., Khandelwal, P.J., Stanczyk, B.B., Rebeck, G.W., Moussa, C.E., Beta-amyloid triggers ALS-associated TDP-43 pathology in AD models. Brain Res. 1386 (2011), 191–199.
71. Higashi, S., Iseki, E., Yamamoto, R., Minegishi, M., Hino, H., Fujisawa, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., Kosaka, K., Arai, H., Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184 (2007), 284–294.
72. Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A.M., Czaja, M.J., Autophagy regulates lipid metabolism. Nature 458 (2009), 1131–1135.
73. Foley, P., Lipids in Alzheimer's disease: a century-old story. Biochim. Biophys. Acta 1801 (2010), 750–753.
74. Di Paolo, G., Kim, T.W., Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 12 (2011), 284–296.
75. Walter, J., van Echten-Deckert, G., Cross-talk of membrane lipids and Alzheimer-related proteins. Mol. Neurodegener., 8, 2013, 34.
76. Christian, P., Sacco, J., Adeli, K., Autophagy Emerging roles in lipid homeostasis and metabolic control. Biochim. Biophys. Acta 2013 (1831), 819–824.
77. Bertram, L., Tanzi, R.E., Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 9 (2008), 768–778.
78. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., Simons, K., Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 6460–6464.
79. Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Kuhl, S., Bertsch, T., von Bergmann, K., Hennerici, M., Beyreuther, K., Hartmann, T., Simvastatin strongly reduces levels of Alzheimer's disease beta −amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 5856–5861.
80. He, X., Huang, Y., Li, B., Gong, C.X., Schuchman, E.H., Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol. Aging 31 (2010), 398–408.
81. Grimm, M.O., Grimm, H.S., Patzold, A.J., Zinser, E.G., Halonen, R., Duering, M., Tschape, J.A., De Strooper, B., Muller, U., Shen, J., Hartmann, T., Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell Biol. 7 (2005), 1118–1123.
82. Sawamura, N., Ko, M., Yu, W., Zou, K., Hanada, K., Suzuki, T., Gong, J.S., Yanagisawa, K., Michikawa, M., Modulation of amyloid precursor protein cleavage by cellular sphingolipids. J. Biol. Chem. 279 (2004), 11984–11991.
83. Gellermann, G.P., Appel, T.R., Davies, P., Diekmann, S., Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and sphingolipids. Biol. Chem. 387 (2006), 1267–1274.
84. Gray, E.G., Paula-Barbosa, M., Roher, A., Alzheimer's disease: paired helical filaments and cytomembranes. Neuropathol. Appl. Neurobiol. 13 (1987), 91–110.
85. Elbaum-Garfinkle, S., Ramlall, T., Rhoades, E., The role of the lipid bilayer in tau aggregation. Biophys. J. 98 (2010), 2722–2730.
86. Georgieva, E.R., Xiao, S., Borbat, P.P., Freed, J.H., Eliezer, D., Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats. Biophys. J. 107 (2014), 1441–1452.
87. Galasso, A., Cameron, C.S., Frenguelli, B.G., Moffat, K.G., An AMPK-dependent regulatory pathway in tau-mediated toxicity. Biol. Open, 2017, 10.1242/bio.022863.
88. Settembre, C., Zoncu, R., Medina, D.L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M.C., Facchinetti, V., Sabatini, D.M., Ballabio, A., A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31 (2012), 1095–1108.
89. Polito, V.A., Li, H., Martini-Stoica, H., Wang, B., Yang, L., Xu, Y., Swartzlander, D.B., Palmieri, M., di Ronza, A., Lee, V.M., Sardiello, M., Ballabio, A., Zheng, H., Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med 6 (2014), 1142–1160.
90. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A., Morgan, A.R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M.K., Brayne, C., Rubinsztein, D.C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K.S., Passmore, P.A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A.D., Love, S., Kehoe, P.G., Hardy, J., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., Heun, R., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A.M., Kauwe, J.S., Cruchaga, C., Nowotny, P., Morris, J.C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Livingston, G., Bass, N.J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C.E., Tsolaki, M., Singleton, A.B., Guerreiro, R., Muhleisen, T.W., Nothen, M.M., Moebus, S., Jockel, K.H., Klopp, N., Wichmann, H.E., Carrasquillo, M.M., Pankratz, V.S., Younkin, S.G., Holmans, P.A., O'Donovan, M., Owen, M.J., Williams, J., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41 (2009), 1088–1093.
91. Cruchaga, C., Kauwe, J.S., Harari, O., Jin, S.C., Cai, Y., Karch, C.M., Benitez, B.A., Jeng, A.T., Skorupa, T., Carrell, D., Bertelsen, S., Bailey, M., McKean, D., Shulman, J.M., De Jager, P.L., Chibnik, L., Bennett, D.A., Arnold, S.E., Harold, D., Sims, R., Gerrish, A., Williams, J., Van Deerlin, V.M., Lee, V.M., Shaw, L.M., Trojanowski, J.Q., Haines, J.L., Mayeux, R., Pericak-Vance, M.A., Farrer, L.A., Schellenberg, G.D., Peskind, E.R., Galasko, D., Fagan, A.M., Holtzman, D.M., Morris, J.C., G., Consortium, I. Alzheimer's Disease Neuroimaging, C. Alzheimer Disease Genetics, Goate, A.M., GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron 78 (2013), 256–268.
92. Jun, G., Naj, A.C., Beecham, G.W., Wang, L.S., Buros, J., Gallins, P.J., Buxbaum, J.D., N, Ertekin-Taner, Fallin, M.D., Friedland, R., Inzelberg, R., Kramer, P., Rogaeva, E., St George-Hyslop, P., C. Alzheimer's Disease Genetics, Cantwell, L.B., Dombroski, B.A., Saykin, A.J., Reiman, E.M., Bennett, D.A., Morris, J.C., Lunetta, K.L., Martin, E.R., Montine, T.J., Goate, A.M., Blacker, D., Tsuang, D.W., Beekly, D., Cupples, L.A., Hakonarson, H., Kukull, W., Foroud, T.M., Haines, J., Mayeux, R., Farrer, L.A., M.A, Pericak-Vance, Schellenberg, G.D., Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 67 (2010), 1473–1484.
93. Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., Russo, G., Thorton-Wells, T.A., Jones, N., Smith, A.V., Chouraki, V., Thomas, C., Ikram, M.A., Zelenika, D., Vardarajan, B.N., Kamatani, Y., Lin, C.F., Gerrish, A., Schmidt, H., Kunkle, B., Dunstan, M.L., Ruiz, A., Bihoreau, M.T., Choi, S.H., Reitz, C., Pasquier, F., Cruchaga, C., Craig, D., Amin, N., Berr, C., Lopez, O.L., De Jager, P.L., Deramecourt, V., Johnston, J.A., Evans, D., Lovestone, S., Letenneur, L., Moron, F.J., Rubinsztein, D.C., Eiriksdottir, G., Sleegers, K., Goate, A.M., Fievet, N., Huentelman, M.W., Gill, M., Brown, K., Kamboh, M.I., Keller, L., Barberger-Gateau, P., McGuiness, B., Larson, E.B., Green, R., Myers, A.J., Dufouil, C., Todd, S., Wallon, D., Love, S., Rogaeva, E., Gallacher, J., St George-Hyslop, P., Clarimon, J., Lleo, A., Bayer, A., Tsuang, D.W., Yu, L., Tsolaki, M., Bossu, P., Spalletta, G., Proitsi, P., Collinge, J., Sorbi, S., Sanchez-Garci, F., Fox, N.C., Hardy, J., Deniz Naranjo, M.C., Bosco, P., Clarke, R., Brayne, C., Galimberti, D., Mancuso, M., Matthews, F., I. European Alzheimer's Disease, D. Environmental Risk in Alzheimer's, C. Alzheimer's Disease Genetics, H. Cohorts for, E. Aging Research in Genomic, Moebus, S., Mecocci, P., Del Zompo, M., Maier, W., Hampel, H., Pilotto, A., Bullido, M., Panza, F., Caffarra, P., et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45 (2013), 1452–1458.
94. Naj, A.C., Jun, G., Reitz, C., Kunkle, B.W., Perry, W., Park, Y.S., Beecham, G.W., Rajbhandary, R.A., Hamilton-Nelson, K.L., Wang, L.S., Kauwe, J.S., Huentelman, M.J., Myers, A.J., Bird, T.D., Boeve, B.F., Baldwin, C.T., Jarvik, G.P., Crane, P.K., Rogaeva, E., Barmada, M.M., Demirci, F.Y., Cruchaga, C., Kramer, P.L., Ertekin-Taner, N., Hardy, J., Graff-Radford, N.R., Green, R.C., Larson, E.B., George-Hyslop, P.H., Buxbaum, J.D., Evans, D.A., Schneider, J.A., Lunetta, K.L., Kamboh, M.I., Saykin, A.J., Reiman, E.M., De Jager, P.L., Bennett, D.A., Morris, J.C., Montine, T.J., Goate, A.M., Blacker, D., Tsuang, D.W., Hakonarson, H., Kukull, W.A., Foroud, T.M., Martin, E.R., Haines, J.L., Mayeux, R.P., Farrer, L.A., Schellenberg, G.D., Pericak-Vance, M.A., Alzheimer Disease Genetics, C., Albert, M.S., Albin, R.L., Apostolova, L.G., Arnold, S.E., Barber, R., Barnes, L.L., Beach, T.G., Becker, J.T., Beekly, D., Bigio, E.H., Bowen, J.D., Boxer, A., Burke, J.R., Cairns, N.J., Cantwell, L.B., Cao, C., Carlson, C.S., Carney, R.M., Carrasquillo, M.M., Carroll, S.L., Chui, H.C., Clark, D.G., Corneveaux, J., Cribbs, D.H., Crocco, E.A., DeCarli, C., DeKosky, S.T., Dick, M., Dickson, D.W., Duara, R., Faber, K.M., Fallon, K.B., Farlow, M.R., Ferris, S., Frosch, M.P., Galasko, D.R., Ganguli, M., Gearing, M., Geschwind, D.H., Ghetti, B., Gilbert, J.R., Glass, J.D., Growdon, J.H., Hamilton, R.L., Harrell, L.E., Head, E., Honig, L.S., Hulette, C.M., Hyman, B.T., Jicha, G.A., Jin, L.W., Karydas, A., Kaye, J.A., Kim, R., Koo, E.H., Kowall, N.W., Kramer, J.H., LaFerla, F.M., Lah, J.J., Leverenz, J.B., Levey, A.I., Li, G., Lieberman, A.P., Lin, C.F., Lopez, O.L., Lyketsos, C.G., Mack, W.J., Martiniuk, F., Mash, D.C., Masliah, E., McCormick, W.C., McCurry, S.M., McDavid, A.N., McKee, A.C., Mesulam, M., Miller, B.L., Miller, C.A., Miller, J.W., Murrell, J.R., Olichney, J.M., Pankratz, V.S., Parisi, J.E., Paulson, H.L., Peskind, E., Petersen, R.C., Pierce, A., Poon, W.W., Potter, H., Quinn, J.F., Raj, A., Raskind, M., Reisberg, B., Ringman, J.M., Roberson, E.D., Rosen, H.J., Rosenberg, R.N., Sano, M., Schneider, L.S., Seeley, W.W., Smith, A.G., Sonnen, J.A., Spina, S., Stern, R.A., Tanzi, R.E., Thornton-Wells, T.A., Trojanowski, J.Q., Troncoso, J.C., Valladares, O., Van Deerlin, V.M., Van Eldik, L.J., Vardarajan, B.N., Vinters, H.V., Vonsattel, J.P., Weintraub, S., Welsh-Bohmer, K.A., Williamson, J., Wishnek, S., Woltjer, R.L., Wright, C.B., Younkin, S.G., Yu, C.E., Yu, L., Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 71 (2014), 1394–1404.
95. Yao, P.J., Zhang, P., Mattson, M.P., Furukawa, K., Heterogeneity of endocytic proteins: distribution of clathrin adaptor proteins in neurons and glia. Neuroscience 121 (2003), 25–37.
96. Bushlin, I., Petralia, R.S., Wu, F., Harel, A., Mughal, M.R., Mattson, M.P., Yao, P.J., Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons. J. Neurosci. 28 (2008), 10257–10271.
97. Baig, S., Joseph, S.A., Tayler, H., Abraham, R., Owen, M.J., Williams, J., Kehoe, P.G., Love, S., Distribution and expression of picalm in Alzheimer disease. J. Neuropathol. Exp. Neurol. 69 (2010), 1071–1077.
98. Xiao, Q., Gil, S.C., Yan, P., Wang, Y., Han, S., Gonzales, E., Perez, R., Cirrito, J.R., Lee, J.M., Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J. Biol. Chem. 287 (2012), 21279–21289.
99. Kanatsu, K., Hori, Y., Takatori, S., Watanabe, T., Iwatsubo, T., Tomita, T., Partial loss of CALM function reduces Abeta42 production and amyloid deposition in vivo. Hum. Mol. Genet. 25 (2016), 3988–3997.
100. Kanatsu, K., Morohashi, Y., Suzuki, M., Kuroda, H., Watanabe, T., Tomita, T., Iwatsubo, T., Decreased CALM expression reduces Abeta42 to total Abeta ratio through clathrin-mediated endocytosis of gamma-secretase. Nat. Commun., 5, 2014, 3386.
101. Zhao, Z., Sagare, A.P., Ma, Q., Halliday, M.R., Kong, P., Kisler, K., Winkler, E.A., Ramanathan, A., Kanekiyo, T., Bu, G., Owens, N.C., Rege, S.V., Si, G., Ahuja, A., Zhu, D., Miller, C.A., Schneider, J.A., Maeda, M., Maeda, T., Sugawara, T., Ichida, J.K., Zlokovic, B.V., Central role for PICALM in amyloid-beta blood-brain barrier transcytosis and clearance. Nat. Neurosci. 18 (2015), 978–987.
102. Moreau, K., Fleming, A., Imarisio, S., Lopez Ramirez, A., Mercer, J.L., Jimenez-Sanchez, M., Bento, C.F., Puri, C., Zavodszky, E., Siddiqi, F., Lavau, C.P., Betton, M., O'Kane, C.J., Wechsler, D.S., Rubinsztein, D.C., PICALM modulates autophagy activity and tau accumulation. Nat. Commun., 5, 2014, 4998.
103. Miyagawa, T., Ebinuma, I., Morohashi, Y., Hori, Y., Young Chang, M., Hattori, H., Maehara, T., Yokoshima, S., Fukuyama, T., Tsuji, S., Iwatsubo, T., Prendergast, G.C., Tomita, T., BIN1 regulates BACE1 intracellular trafficking and amyloid-beta production. Hum. Mol. Genet. 25 (2016), 2948–2958.
104. Chapuis, J., Hansmannel, F., Gistelinck, M., Mounier, A., Van Cauwenberghe, C., Kolen, K.V., Geller, F., Sottejeau, Y., Harold, D., Dourlen, P., Grenier-Boley, B., Kamatani, Y., Delepine, B., Demiautte, F., Zelenika, D., Zommer, N., Hamdane, M., Bellenguez, C., Dartigues, J.F., Hauw, J.J., Letronne, F., Ayral, A.M., Sleegers, K., Schellens, A., Broeck, L.V., Engelborghs, S., De Deyn, P.P., Vandenberghe, R., O'Donovan, M., Owen, M., Epelbaum, J., Mercken, M., Karran, E., Bantscheff, M., Drewes, G., Joberty, G., Campion, D., Octave, J.N., Berr, C., Lathrop, M., Callaerts, P., Mann, D., Williams, J., Buee, L., Dewachter, I., Van Broeckhoven, C., Amouyel, P., Moechars, D., Dermaut, B., Lambert, J.C., G. consortium, Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol. Psychiatry 18 (2013), 1225–1234.
105. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P.V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A.I., Lah, J.J., Rujescu, D., Hampel, H., Giegling, I., Andreassen, O.A., Engedal, K., Ulstein, I., Djurovic, S., Ibrahim-Verbaas, C., Hofman, A., Ikram, M.A., van Duijn, C.M., Thorsteinsdottir, U., Kong, A., Stefansson, K., Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368 (2013), 107–116.
106. Jonsson, T., Stefansson, K., TREM2 and neurodegenerative disease. N. Engl. J. Med. 369 (2013), 1568–1569.
107. Kleinberger, G., Yamanishi, Y., Suarez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., Tahirovic, S., Lleo, A., Alcolea, D., Fortea, J., Willem, M., Lammich, S., Molinuevo, J.L., Sanchez-Valle, R., Antonell, A., Ramirez, A., Heneka, M.T., Sleegers, K., van der Zee, J., Martin, J.J., Engelborghs, S., Demirtas-Tatlidede, A., Zetterberg, H., Van Broeckhoven, C., Gurvit, H., Wyss-Coray, T., Hardy, J., Colonna, M., Haass, C., TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci. Transl. Med., 6, 2014, 243ra286.
108. Lucin, K.M., O'Brien, C.E., Bieri, G., Czirr, E., Mosher, K.I., Abbey, R.J., Mastroeni, D.F., Rogers, J., Spencer, B., Masliah, E., Wyss-Coray, T., Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron 79 (2013), 873–886.
109. Ulland, T.K., Song, W.M., Huang, S.C., Ulrich, J.D., Sergushichev, A., Beatty, W.L., Loboda, A.A., Zhou, Y., Cairns, N.J., Kambal, A., Loginicheva, E., Gilfillan, S., Cella, M., Virgin, H.W., Unanue, E.R., Wang, Y., Artyomov, M.N., Holtzman, D.M., Colonna, M., TREM2 maintains microglial metabolic fitness in Alzheimer's disease. Cell 170 (2017), 649–663 e613.
110. Vardarajan, B.N., Bruesegem, S.Y., Harbour, M.E., Inzelberg, R., Friedland, R., St George-Hyslop, P., Seaman, M.N., Farrer, L.A., Identification of Alzheimer disease-associated variants in genes that regulate retromer function. Neurobiol. Aging, 33, 2012 2231 e2215-2231 e2230.
111. Yin, J., Liu, X., He, Q., Zhou, L., Yuan, Z., Zhao, S., Vps35-dependent recycling of Trem2 regulates microglial function. Traffic 17 (2016), 1286–1296.
112. Bonifacino, J.S., Rojas, R., Retrograde transport from endosomes to the trans-Golgi network. Nat. Rev. Mol. Cell Biol. 7 (2006), 568–579.
113. Zavodszky, E., Seaman, M.N., Moreau, K., Jimenez-Sanchez, M., Breusegem, S.Y., Harbour, M.E., Rubinsztein, D.C., Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy. Nat. Commun., 5, 2014, 3828.
114. Wang, W., Wang, X., Fujioka, H., Hoppel, C., Whone, A.L., Caldwell, M.A., Cullen, P.J., Liu, J., Zhu, X., Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat. Med. 22 (2016), 54–63.
115. Wen, L., Tang, F.L., Hong, Y., Luo, S.W., Wang, C.L., He, W., Shen, C., Jung, J.U., Xiong, F., Lee, D.H., Zhang, Q.G., Brann, D., Kim, T.W., Yan, R., Mei, L., Xiong, W.C., VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J. Cell Biol. 195 (2011), 765–779.
116. Rogaeva, E., Meng, Y., Lee, J.H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C.T., Cheng, R., Hasegawa, H., Chen, F., Shibata, N., Lunetta, K.L., Pardossi-Piquard, R., Bohm, C., Wakutani, Y., Cupples, L.A., Cuenco, K.T., Green, R.C., Pinessi, L., Rainero, I., Sorbi, S., Bruni, A., Duara, R., Friedland, R.P., Inzelberg, R., Hampe, W., Bujo, H., Song, Y.Q., Andersen, O.M., Willnow, T.E., Graff-Radford, N., Petersen, R.C., Dickson, D., Der, S.D., Fraser, P.E., Schmitt-Ulms, G., Younkin, S., Mayeux, R., Farrer, L.A., St George-Hyslop, P., The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39 (2007), 168–177.
117. Pottier, C., Hannequin, D., Coutant, S., Rovelet-Lecrux, A., Wallon, D., Rousseau, S., Legallic, S., Paquet, C., Bombois, S., Pariente, J., Thomas-Anterion, C., Michon, A., Croisile, B., Etcharry-Bouyx, F., Berr, C., Dartigues, J.F., Amouyel, P., Dauchel, H., Boutoleau-Bretonniere, C., Thauvin, C., Frebourg, T., Lambert, J.C., Campion, D., Collaborators, P.G., High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol. Psychiatry 17 (2012), 875–879.
118. Caglayan, S., Takagi-Niidome, S., Liao, F., Carlo, A.S., Schmidt, V., Burgert, T., Kitago, Y., Fuchtbauer, E.M., Fuchtbauer, A., Holtzman, D.M., Takagi, J., Willnow, T.E., Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer's disease mutation. Sci. Transl. Med., 6, 2014, 223ra220.
119. Dodson, S.E., Andersen, O.M., Karmali, V., Fritz, J.J., Cheng, D., Peng, J., Levey, A.I., Willnow, T.E., Lah, J.J., Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease. J. Neurosci. 28 (2008), 12877–12886.
120. Yu, L., Chibnik, L.B., Srivastava, G.P., Pochet, N., Yang, J., Xu, J., Kozubek, J., Obholzer, N., Leurgans, S.E., Schneider, J.A., Meissner, A., De Jager, P.L., Bennett, D.A., Association of brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 72 (2015), 15–24.
121. Swerdlow, R.H., Khan, S.M., A. mitochondrial cascade hypothesis for sporadic Alzheimer's disease. Med. Hypotheses 63 (2004), 8–20.
122. Kapogiannis, D., Mattson, M.P., Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 10 (2011), 187–198.
123. Yao, J., Irwin, R.W., Zhao, L., Nilsen, J., Hamilton, R.T., Brinton, R.D., Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 14670–14675.
124. Mao, P., Manczak, M., Calkins, M.J., Truong, Q., Reddy, T.P., Reddy, A.P., Shirendeb, U., Lo, H.H., Rabinovitch, P.S., Reddy, P.H., Mitochondria-targeted catalase reduces abnormal APP processing, amyloid beta production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. Hum. Mol. Genet. 21 (2012), 2973–2990.
125. Hoglinger, G.U., Lannuzel, A., Khondiker, M.E., Michel, P.P., Duyckaerts, C., Feger, J., Champy, P., Prigent, A., Medja, F., Lombes, A., Oertel, W.H., Ruberg, M., Hirsch, E.C., The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J. Neurochem. 95 (2005), 930–939.
126. Ye, X., Sun, X., Starovoytov, V., Cai, Q., Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains. Hum. Mol. Genet. 24 (2015), 2938–2951.
127. Andorfer, C., Kress, Y., Espinoza, M., de Silva, R., Tucker, K.L., Barde, Y.A., Duff, K., Davies, P., Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86 (2003), 582–590.
128. Plucinska, K., Crouch, B., Koss, D., Robinson, L., Siebrecht, M., Riedel, G., Platt, B., Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes. J. Neurosci. 34 (2014), 10710–10728.
129. Schwab, C., Hosokawa, M., McGeer, P.L., Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp. Neurol. 188 (2004), 52–64.
130. Sproul, A.A., Being human: the role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models. Mol. Aspects Med. 43-44 (2015), 54–65.
131. Reddy, K., Cusack, C.L., Nnah, I.C., Khayati, K., Saqcena, C., Huynh, T.B., Noggle, S.A., Ballabio, A., Dobrowolski, R., Dysregulation of nutrient sensing and CLEARance in presenilin deficiency. Cell Rep. 14 (2016), 2166–2179.
132. Martin-Maestro, P., Gargini, R., Sproul, A.A., Garcia, E., Anton, L.C., Noggle, S., Arancio, O., Avila, J., Garcia-Escudero, V., Mitophagy failure in fibroblasts and iPSC-derived neurons of Alzheimer's disease-associated presenilin 1 mutation. Front. Mol. Neurosci., 10, 2017, 291.
133. Silva, M.C., Cheng, C., Mair, W., Almeida, S., Fong, H., Biswas, M.H.U., Zhang, Z., Huang, Y., Temple, S., Coppola, G., Geschwind, D.H., Karydas, A., Miller, B.L., Kosik, K.S., Gao, F.B., Steen, J.A., Haggarty, S.J., Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability. Stem Cell Rep. 7 (2016), 325–340.
134. Biswas, M.H.U., Almeida, S., Lopez-Gonzalez, R., Mao, W., Zhang, Z., Karydas, A., Geschwind, M.D., Biernat, J., Mandelkow, E.M., Futai, K., Miller, B.L., Gao, F.B., MMP-9 and MMP-2 contribute to neuronal cell death in iPSC models of frontotemporal dementia with MAPT mutations. Stem Cell Rep. 7 (2016), 316–324.
135. Almeida, S., Gascon, E., Tran, H., Chou, H.J., Gendron, T.F., Degroot, S., Tapper, A.R., Sellier, C., Charlet-Berguerand, N., Karydas, A., Seeley, W.W., Boxer, A.L., Petrucelli, L., Miller, B.L., Gao, F.B., Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 126 (2013), 385–399.
136. Madill, M., McDonagh, K., Ma, J., Vajda, A., McLoughlin, P., O'Brien, T., Hardiman, O., Shen, S., Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol. Brain, 10, 2017, 22.
137. Vanhauwaert, R., Kuenen, S., Masius, R., Bademosi, A., Manetsberger, J., Schoovaerts, N., Bounti, L., Gontcharenko, S., Swerts, J., Vilain, S., Picillo, M., Barone, P., Munshi, S.T., de Vrij, F.M., Kushner, S.A., Gounko, N.V., Mandemakers, W., Bonifati, V., Meunier, F.A., Soukup, S.F., Verstreken, P., The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals. EMBO J. 36 (2017), 1392–1411.
138. Fernandes, H.J., Hartfield, E.M., Christian, H.C., Emmanoulidou, E., Zheng, Y., Booth, H., Bogetofte, H., Lang, C., Ryan, B.J., Sardi, S.P., Badger, J., Vowles, J., Evetts, S., Tofaris, G.K., Vekrellis, K., Talbot, K., Hu, M.T., James, W., Cowley, S.A., Wade-Martins, R., Stress, E.R., Autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons. Stem Cell Rep. 6 (2016), 342–356.
139. Siddiqui, A., Bhaumik, D., Chinta, S.J., Rane, A., Rajagopalan, S., Lieu, C.A., Lithgow, G.J., Andersen, J.K., Mitochondrial quality control via the PGC1alpha-TFEB signaling pathway is compromised by parkin Q311X mutation but independently restored by rapamycin. J. Neurosci. 35 (2015), 12833–12844.
140. Ohta, E., Nihira, T., Uchino, A., Imaizumi, Y., Okada, Y., Akamatsu, W., Takahashi, K., Hayakawa, H., Nagai, M., Ohyama, M., Ryo, M., Ogino, M., Murayama, S., Takashima, A., Nishiyama, K., Mizuno, Y., Mochizuki, H., Obata, F., Okano, H., I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3beta signaling pathway. Hum. Mol. Genet. 24 (2015), 4879–4900.
141. Schondorf, M., Aureli, F.E., McAllister, C.J., Hindley, F., Mayer, B., Schmid, S.P., Sardi, M., Valsecchi, S., Hoffmann, L.K., Schwarz, U., Hedrich, D., Berg, L.S., Shihabuddin, J., Hu, J., Pruszak, S.P., Gygi, S., Sonnino, T., Gasser, M., iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun., 5, 2014, 4028.
142. Su, Y.C., Qi, X., Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum. Mol. Genet. 22 (2013), 4545–4561.
143. Orenstein, S.J., Kuo, S.H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L.S., Dauer, W., Consiglio, A., Raya, A., Sulzer, D., Cuervo, A.M., Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 16 (2013), 394–406.
144. Sanchez-Danes, A., Richaud-Patin, Y., Carballo-Carbajal, I., Jimenez-Delgado, S., Caig, C., Mora, S., Di Guglielmo, C., Ezquerra, M., Patel, B., Giralt, A., Canals, J.M., Memo, M., Alberch, J., Lopez-Barneo, J., Vila, M., Cuervo, A.M., Tolosa, E., Consiglio, A., Raya, A., Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol. Med. 4 (2012), 380–395.
145. Awad, O., Sarkar, C., Panicker, L.M., Miller, D., Zeng, X., Sgambato, J.A., Lipinski, M.M., Feldman, R.A., Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells. Hum. Mol. Genet. 24 (2015), 5775–5788.
146. Kuo, S.Y., Castoreno, A.B., Aldrich, L.N., Lassen, K.G., Goel, G., Dancik, V., Kuballa, P., Latorre, I., Conway, K.L., Sarkar, S., Maetzel, D., Jaenisch, R., Clemons, P.A., Schreiber, S.L., Shamji, A.F., Xavier, R.J., Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E4281–E4287.
147. Maetzel, D., Sarkar, S., Wang, H., Abi-Mosleh, L., Xu, P., Cheng, A.W., Gao, Q., Mitalipova, M., Jaenisch, R., Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick type C patient-specific iPS cells. Stem cell reports 2 (2014), 866–880.
148. Lee, H., Lee, J.K., Park, M.H., Hong, Y.R., Marti, H.H., Kim, H., Okada, Y., Otsu, M., Seo, E.J., Park, J.H., Bae, J.H., Okino, N., He, X., Schuchman, E.H., Bae, J.S., Jin, H.K., Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons. Nat. Commun., 5, 2014, 5514.
149. Imamura, K., Izumi, Y., Watanabe, A., Tsukita, K., Woltjen, K., Yamamoto, T., Hotta, A., Kondo, T., Kitaoka, S., Ohta, A., Tanaka, A., Watanabe, D., Morita, M., Takuma, H., Tamaoka, A., Kunath, T., Wray, S., Furuya, H., Era, T., Makioka, K., Okamoto, K., Fujisawa, T., Nishitoh, H., Homma, K., Ichijo, H., Julien, J.P., Obata, N., Hosokawa, M., Akiyama, H., Kaneko, S., Ayaki, T., Ito, H., Kaji, R., Takahashi, R., Yamanaka, S., Inoue, H., The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci. Transl. Med., 9, 2017.
150. Barmada, S.J., Serio, A., Arjun, A., Bilican, B., Daub, A., Ando, D.M., Tsvetkov, A., Pleiss, M., Li, X., Peisach, D., Shaw, C., Chandran, S., Finkbeiner, S., Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 10 (2014), 677–685.
151. Cortes, C.J., Miranda, H.C., Frankowski, H., Batlevi, Y., Young, J.E., Le, A., Ivanov, N., Sopher, B.L., Carromeu, C., Muotri, A.R., Garden, G.A., La Spada, A.R., Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat. Neurosci. 17 (2014), 1180–1189.
152. Rizzo, F., Ramirez, A., Compagnucci, C., Salani, S., Melzi, V., Bordoni, A., Fortunato, F., Niceforo, A., Bresolin, N., Comi, G.P., Bertini, E., Nizzardo, M., Corti, S., Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin. Sci. Rep., 7, 2017, 46271.
153. Rizzo, F., Ronchi, D., Salani, S., Nizzardo, M., Fortunato, F., Bordoni, A., Stuppia, G., Del Bo, R., Piga, D., Fato, R., Bresolin, N., Comi, G.P., Corti, S., Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons. Hum. Mol. Genet. 25 (2016), 4266–4281.
154. Cooper, H.M., Yang, Y., Ylikallio, E., Khairullin, R., Woldegebriel, R., Lin, K.L., Euro, L., Palin, E., Wolf, A., Trokovic, R., Isohanni, P., Kaakkola, S., Auranen, M., Lonnqvist, T., Wanrooij, S., Tyynismaa, H., ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia. Hum. Mol. Genet. 26 (2017), 1432–1443.
155. Holler, C.J., Taylor, G., McEachin, Z.T., Deng, Q., Watkins, W.J., Hudson, K., Easley, C.A., Hu, W.T., Hales, C.M., Rossoll, W., Bassell, G.J., Kukar, T., Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia. Mol. Neurodegener., 11, 2016, 46.
156. Jiang, T., Yu, J.T., Zhu, X.C., Zhang, Q.Q., Cao, L., Wang, H.F., Tan, M.S., Gao, Q., Qin, H., Zhang, Y.D., Tan, L., Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance. Neuropharmacology 85 (2014), 121–130.
157. Du, J., Liang, Y., Xu, F., Sun, B., Wang, Z., Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice. J. Pharm. Pharmacol. 65 (2013), 1753–1756.
158. Schaeffer, V., Goedert, M., Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy 8 (2012), 1686–1687.
159. Congdon, E.E., Wu, J.W., Myeku, N., Figueroa, Y.H., Herman, M., Marinec, P.S., Gestwicki, J.E., Dickey, C.A., Yu, W.H., Duff, K.E., Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 8 (2012), 609–622.
160. Kast, D.J., Dominguez, R., The cytoskeleton-autophagy connection. Curr. Biol. 27 (2017), R318–R326.
161. Seyb, K.I., Ansar, S., Bean, J., Michaelis, M.L., Beta-Amyloid and endoplasmic reticulum stress responses in primary neurons: effects of drugs that interact with the cytoskeleton. J. Mol. Neurosci. 28 (2006), 111–123.
162. Brunden, K.R., Zhang, B., Carroll, J., Yao, Y., Potuzak, J.S., Hogan, A.M., Iba, M., James, M.J., Xie, S.X., Ballatore, C., Smith, A.B., 3rd, V.M., Lee, J.Q., Trojanowski, Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 30 (2010), 13861–13866.
163. Bourdenx, M., Daniel, J., Genin, E., Soria, F.N., Blanchard-Desce, M., Bezard, E., Dehay, B., Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases. Autophagy 12 (2016), 472–483.
164. Gambaryan, P.Y., Kondrasheva, I.G., Severin, E.S., Guseva, A.A., Kamensky, A.A., Increasing the efficiency of Parkinson's disease treatment using a poly(lactic-co-glycolic acid) (PLGA) based L-DOPA delivery system. Exp. Neurobiol. 23 (2014), 246–252.